108 related articles for article (PubMed ID: 15064727)
21. Arsenite inhibits p53 phosphorylation, DNA binding activity, and p53 target gene p21 expression in mouse epidermal JB6 cells.
Tang F; Liu G; He Z; Ma WY; Bode AM; Dong Z
Mol Carcinog; 2006 Nov; 45(11):861-70. PubMed ID: 16739126
[TBL] [Abstract][Full Text] [Related]
22. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
[TBL] [Abstract][Full Text] [Related]
23. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
[TBL] [Abstract][Full Text] [Related]
24. The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.
Retzlaff M; Rohrberg J; Küpper NJ; Lagleder S; Bepperling A; Manzenrieder F; Peschek J; Kessler H; Buchner J
J Mol Biol; 2013 Jan; 425(1):144-55. PubMed ID: 23103206
[TBL] [Abstract][Full Text] [Related]
25. The C-terminus of p53: the more you learn the less you know.
Ahn J; Prives C
Nat Struct Biol; 2001 Sep; 8(9):730-2. PubMed ID: 11524665
[No Abstract] [Full Text] [Related]
26. Post-translational modification of p53.
Meek DW
Semin Cancer Biol; 1994 Jun; 5(3):203-10. PubMed ID: 7948948
[TBL] [Abstract][Full Text] [Related]
27. Fast, qualitative analysis of p53 phosphorylation by protein kinases.
Chène P
Biotechniques; 2000 Feb; 28(2):240-2. PubMed ID: 10683732
[No Abstract] [Full Text] [Related]
28. Regulation of the DNA binding of p53 by its interaction with protein kinase CK2.
Prowald A; Schuster N; Montenarh M
FEBS Lett; 1997 May; 408(1):99-104. PubMed ID: 9180277
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.
Hupp TR; Lane DP
Cold Spring Harb Symp Quant Biol; 1994; 59():195-206. PubMed ID: 7587070
[TBL] [Abstract][Full Text] [Related]
30. Forewarned is four-armed.
Surridge C
Nature; 1994 Dec; 372(6505):482. PubMed ID: 7984245
[TBL] [Abstract][Full Text] [Related]
31. Post-translational modifications and activation of p53 by genotoxic stresses.
Appella E; Anderson CW
Eur J Biochem; 2001 May; 268(10):2764-72. PubMed ID: 11358490
[TBL] [Abstract][Full Text] [Related]
32. In vitro folding and characterization of the p53 DNA binding domain.
Klein C; Hesse F; Dehner A; Engh RA; Schwaiger M; Hansen S
Biol Chem; 2004 Jan; 385(1):95-102. PubMed ID: 14977051
[TBL] [Abstract][Full Text] [Related]
33. p53 Loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance.
Thakur B; Ray P
Mol Oncol; 2016 Oct; 10(8):1283-95. PubMed ID: 27401370
[TBL] [Abstract][Full Text] [Related]
34. Small peptides activate the latent sequence-specific DNA binding function of p53.
Hupp TR; Sparks A; Lane DP
Cell; 1995 Oct; 83(2):237-45. PubMed ID: 7585941
[TBL] [Abstract][Full Text] [Related]
35. p53 RNA interactions: new clues in an old mystery.
Riley KJ; Maher LJ
RNA; 2007 Nov; 13(11):1825-33. PubMed ID: 17804642
[TBL] [Abstract][Full Text] [Related]
36. Recognition of DNA modified by antitumor cisplatin by "latent" and "active" protein p53.
Fojta M; Pivonkova H; Brazdova M; Kovarova L; Palecek E; Pospisilova S; Vojtesek B; Kasparkova J; Brabec V
Biochem Pharmacol; 2003 Apr; 65(8):1305-16. PubMed ID: 12694871
[TBL] [Abstract][Full Text] [Related]
37. Casein kinase 2 inhibits the renaturation of complementary DNA strands mediated by p53 protein.
Filhol O; Baudier J; Chambaz EM; Cochet C
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):331-5. PubMed ID: 8645226
[TBL] [Abstract][Full Text] [Related]
38. A tetraguanidinium ligand binds to the surface of the tetramerization domain of protein P53.
Salvatella X; Martinell M; Gairí M; Mateu MG; Feliz M; Hamilton AD; De Mendoza J; Giralt E
Angew Chem Int Ed Engl; 2004 Jan; 43(2):196-8. PubMed ID: 14695607
[No Abstract] [Full Text] [Related]
39. Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.
Muller P; Chan JM; Simoncik O; Fojta M; Lane DP; Hupp T; Vojtesek B
Protein Sci; 2018 Feb; 27(2):523-530. PubMed ID: 29124793
[TBL] [Abstract][Full Text] [Related]
40. Tetramer formation of tumor suppressor protein p53: Structure, function, and applications.
Kamada R; Toguchi Y; Nomura T; Imagawa T; Sakaguchi K
Biopolymers; 2016 Nov; 106(4):598-612. PubMed ID: 26572807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
